Anat Ashkenazi compensation by year
ELI LILLY Summary Compensation Table · all 4 fiscal years held| Component | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Salary | $850,432 | $940,385 | $1,030,769 | $634,039 |
| Bonus | $0 | $0 | — | — |
| Stock awards | $2,453,000 | $3,135,000 | $3,689,000 | $3,750,501 |
| Option awards | $0 | $0 | — | — |
| Non-equity incentive | $907,816 | $1,128,462 | $1,865,692 | — |
| Pension and deferred compensation | $395,335 | $0 | $951,950 | $538,877 |
| All other | $51,026 | $56,423 | $61,846 | $38,042 |
| Total | $4,657,609 | $5,260,270 | $7,599,257 | $4,961,459 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ELI LILLY & Co DEF 14A filed March 21, 2025, accession 0000059478-25-000107, and prior-year filings. Open the filing on EDGAR.
How this page was built: the ELI LILLY & Co filed document, accession 0000059478-25-000107. Every figure is read from that document and cited to the page and table it appears in. Filed March 21, 2025.
Equity holdings
unvested awards at FY2022 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 11,499 | $4,206,794 | — |
| PSU | 10,458 | $3,825,955 | — |
| PSU | 7,989 | $2,922,696 | — |
| PSU | 6,704 | $2,452,591 | — |
| PSU | 4,114 | $1,505,066 | — |
| PSU | 3,357 | $1,228,125 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in ELI LILLY & Co's FY2022 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments ELI LILLY discloses, by trigger · FY2023| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Retirement | $0 | $9,561,450 | $0 | $9,561,450 |
| Involuntary termination without cause | $0 | $9,561,450 | $0 | $9,561,450 |
| Change in control and involuntary termination | $4,200,000 | $32,000,810 | $62,852 | $36,263,662 |
| Change in control and resignation for good reason | $4,200,000 | $32,000,810 | $62,852 | $36,263,662 |
Per the Potential Payments Upon Termination or Change in Control table in ELI LILLY & Co's FY2023 proxy. Estimates as the company printed them; a dash means it printed no figure.
ELI LILLY’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| David A. Ricks | Chair, President, and Chief Executive Officer | $29,242,926 |
| Daniel M. Skovronsky | Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology | $12,638,744 |
| Anat Hakim | Executive Vice President, General Counsel and Secretary | $7,478,426 |
| Jake Van Naarden | Executive Vice President and President, Loxo@Lilly | $5,773,948 |
| Anat Ashkenazi · this page | Executive Vice President and Chief Financial Officer | $4,961,459 |
| Lucas Montarce | Executive Vice President and Chief Financial Officer | $2,948,519 |
| Gordon Brooks | Interim CFO and Group Vice President - Controller and Corporate Strategy | $2,740,458 |
The full ELI LILLY compensation record
free company briefThis page is one person within ELI LILLY's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the ELI LILLY proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ELI LILLY's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.